Christopher Posner - 02 Nov 2023 Form 4 Insider Report for Cara Therapeutics, Inc. (TVRD)

Role
President and CEO, Director
Signature
/s/Darren DeStefano, Attorney-in-Fact
Issuer symbol
TVRD
Transactions as of
02 Nov 2023
Net transactions value
-$4,631
Form type
4
Filing time
03 Nov 2023, 16:37:53 UTC
Previous filing
04 Aug 2023
Next filing
05 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale $4,631 -3,796 -2.3% $1.22 164,411 02 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.